BMJ 2004;329:1255 (27 November), doi:10.1136/bmj.329.7477.1255
News
Drug maker urges group to lobby FDA on testosterone for women
Ray Moynihan
Washington, DC
| The first 150 words of the full text of this article appear below. |
The major household products manufacturer Procter & Gamble recently sought support from an international medical society, which it sponsors, asking the group to get involved in a regulatory hearing assessing the company's experimental testosterone patch.
No peer reviewed data on the testosterone patch have been published, but it has been granted a fast track review by the US Food and Drug Administration and will be publicly debated by an advisory panel next week. The patch is the first drug to be assessed for a controversial condition called hypoactive sexual desire disorder.
Procter & Gamble wrote to the International Society for the Study of Women's Sexual Health, whose recent conference it sponsored, urging the society to "participate" in next week's meeting by sending someone to testify or writing a letter.
|
|
More than two million men in the United States take testoterone. Now Procter & Gamble want to
market it to women
|
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Relevant Articles
- Save the FDA
- Alexander S D Spiers
BMJ 2005 330: 308.[Extract] [Full Text] [PDF]
- Is drug regulation failing?
- Kamran Abbasi
BMJ 2004 329: 0.[Extract] [Full Text] [PDF]
- FDA is incapable of protecting US "against another Vioxx"
- Jeanne Lenzer
BMJ 2004 329: 1253.[Extract] [Full Text] [PDF]
- Fix for low sex drive puts reporters in a bad patch
- Ray Moynihan
BMJ 2004 329: 1294.[Extract] [Full Text]
Rapid Responses:
Read all Rapid Responses
- I would be wary of testosterone patches for women for what ever reason
- Aasa H. Reidak
bmj.com, 26 Nov 2004 [Full text] - Breast cancer risk with unopposed testosterone
- Ray M. Schilling, M.D.
bmj.com, 26 Nov 2004 [Full text] - My Personal Testimony - The Efficacy Of Topically Applied Low Dose Testosterone As An Essential Part Of HRT For Menopausal Women
- Marcia L Sudlow
bmj.com, 5 Dec 2004 [Full text] - Testosterone HRT is dangerous
- Ellen C G Grant
bmj.com, 6 Dec 2004 [Full text] - Dangers of testosterone treatment
- Finn Edler von Eyben
bmj.com, 8 Dec 2004 [Full text] - Testosterone Therapy for women, another perspective.
- NIcholas J O'Hara Smith
bmj.com, 11 Dec 2004 [Full text] - The Other Side: Failure in Fair Balance Reporting
- Stanley E Althof, et al.
bmj.com, 1 Jan 2005 [Full text]
This Article
- Full text
- Respond to this article
- Read responses to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Find similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Related Content
-
Menopause (including HRT)
-
Reproductive medicine
-
Medicines regulation
-
Sexual and gender disorders
-
Sexual health
- Relevant Articles
- Find this article in its weekly table of contents
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
- I would be wary of testosterone patches for women for what ever reason Aasa H. Reidak
- Breast cancer risk with unopposed testosterone Ray M. Schilling, M.D.
- My Personal Testimony - The Efficacy Of Topically Applied Low Dose Testosterone As An Essential Part Of HRT For Menopausal Women Marcia L Sudlow
Print issues
